Designer cannabinoids could be the key to pain relief without adverse effects

Iain Greig; Ruth A. Ross

doi:10.1038/d41586-025-00546-w

Designer cannabinoids could be the key to pain relief without adverse effects

Iain Greig^* (Corresponding Author)
, Ruth A. Ross

^*Corresponding author for this work

University of Toronto

Research output: Contribution to journal › Comment/debate

10 Downloads (Pure)

Abstract

Current approaches to pain relief are falling short. Chemically modifying a synthetic cannabinoid could enable scientists to capitalize on the body’s natural pain-killing pathway without evoking drug tolerance or psychoactivity.

Original language	English
Pages (from-to)	45-46
Number of pages	2
Journal	Nature
Volume	640
Issue number	8057
Early online date	5 Mar 2025
DOIs	https://doi.org/10.1038/d41586-025-00546-w
Publication status	Published - 3 Apr 2025

Access to Document

10.1038/d41586-025-00546-wLicence: Unspecified

Greig_etal_N_Designer_Cannabinoids_Could_AAM
This manuscript has been made open access under a Creative Commons Attribution (CC BY) licence under the terms of the University of Aberdeen Research Publications Policy. https://creativecommons.org/licenses/by/4.0/
Accepted author manuscript, 221 KBLicence: CC BY

Cite this

@article{11e18bb2078b4193842db4a9a1f425a9,

title = "Designer cannabinoids could be the key to pain relief without adverse effects",

abstract = "Current approaches to pain relief are falling short. Chemically modifying a synthetic cannabinoid could enable scientists to capitalize on the body{\textquoteright}s natural pain-killing pathway without evoking drug tolerance or psychoactivity.",

author = "Iain Greig and Ross, \{Ruth A.\}",

year = "2025",

month = apr,

day = "3",

doi = "10.1038/d41586-025-00546-w",

language = "English",

volume = "640",

pages = "45--46",

journal = "Nature",

issn = "1476-4687",

publisher = "Nature Research",

number = "8057",

}

TY - JOUR

T1 - Designer cannabinoids could be the key to pain relief without adverse effects

AU - Greig, Iain

AU - Ross, Ruth A.

PY - 2025/4/3

Y1 - 2025/4/3

N2 - Current approaches to pain relief are falling short. Chemically modifying a synthetic cannabinoid could enable scientists to capitalize on the body’s natural pain-killing pathway without evoking drug tolerance or psychoactivity.

AB - Current approaches to pain relief are falling short. Chemically modifying a synthetic cannabinoid could enable scientists to capitalize on the body’s natural pain-killing pathway without evoking drug tolerance or psychoactivity.

UR - https://abdn.elsevierpure.com/en/publications/11e18bb2-078b-4193-842d-b4a9a1f425a9

U2 - 10.1038/d41586-025-00546-w

DO - 10.1038/d41586-025-00546-w

M3 - Comment/debate

C2 - 40045120

SN - 1476-4687

VL - 640

SP - 45

EP - 46

JO - Nature

JF - Nature

IS - 8057

ER -

Designer cannabinoids could be the key to pain relief without adverse effects

Abstract

Access to Document

Other files and links

Fingerprint

Cite this